Alzheimer’s Disease Biomarkers Market Predicted to Reach USD 1.7 billion by 2031, Expanding at a 7.5% CAGR Says, Transparency Market Research Inc. Wilmington, Delaware, United States, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global Alzheimer’s disease biomarkers market is expected to be valued at US$ 953.54...

Cancer Biomarkers Market to Accrue $34.85 Billion, by 2028 - Global Analysis by Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Leukemia, Bladder Cancer) New York, March 09, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, "Cancer Biomarkers Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global...

Alzheimer’s Disease Biomarkers Market to Exceed Value of US$ 1.7 Bn by 2031, Reveals TMR Study Wilmington, Delaware, United States, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - According to the Alzheimer’s disease biomarkers analysis presented in a research report by...

Response to Novel Immune Therapy for Ulcerative Colitis Associated with Genetic and Immune Biomarkers VANCOUVER, British Columbia , Oct. 03, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...